Clara Chen is currently the Asset Lead for Oncology Outcomes Research (O2R) at AstraZeneca. Previously, they served as the Director of Worldwide Health Economics and Outcomes Research for Oncology and Hematology at Bristol Myers Squibb from 2014 to 2023, as well as a Principal Lead Outcomes Researcher at McKesson from 2007 to 2014. Clara briefly worked as a Biostatistician at Scott & White Hospital in 2007. They obtained their degree from The University of Texas Health Science Center at Houston (UTHealth) between 2010 and 2016.
This person is not in the org chart
This person is not in any teams
This person is not in any offices